Trinity Biotech Total Assets 2006-2019 | TRIB

Trinity Biotech total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Trinity Biotech Annual Total Assets
(Millions of US $)
2018 $152
2017 $193
2016 $250
2015 $364
2014 $243
2013 $226
2012 $197
2011 $171
2010 $161
2009 $132
2008 $130
2007 $216
2006 $249
2005 $185
Trinity Biotech Quarterly Total Assets
(Millions of US $)
Q2 2019 $172
Q1 2019 $173
Q4 2018 $151
Q3 2018 $183
Q2 2018 $194
Q1 2018 $195
Q4 2017 $193
Q3 2017 $245
Q2 2017 $245
Q1 2017 $245
Q4 2016 $250
Q3 2016 $360
Q2 2016 $358
Q1 2016 $360
Q4 2015 $364
Q3 2015 $355
Q2 2015 $360
Q1 2015 $247
Q4 2014 $243
Q3 2014 $237
Q2 2014 $238
Q1 2014 $229
Q4 2013 $226
Q3 2013 $223
Q2 2013 $203
Q1 2013 $203
Q4 2012 $197
Q3 2012 $190
Q2 2012 $184
Q1 2012 $182
Q4 2011 $171
Q3 2011 $170
Q2 2011 $168
Q1 2011 $166
Q4 2010 $161
Q3 2010 $158
Q2 2010 $153
Q1 2010 $132
Q4 2009 $132
Q3 2009 $130
Q2 2009 $131
Q1 2009 $125
Q4 2008 $130
Q3 2008 $216
Q2 2008 $217
Q1 2008 $213
Q4 2007 $216
Q3 2007 $246
Q2 2007 $248
Q1 2007 $0
Q4 2006 $249
Q3 2006 $246
Q2 2006 $0
Q1 2006 $0
Q4 2005 $185
Q3 2005 $178
Q2 2005 $161
Q1 2005 $157
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.033B $0.097B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.939B 20.91
Abbott Laboratories (ABT) United States $147.101B 27.65
Stryker (SYK) United States $82.696B 28.60
Boston Scientific (BSX) United States $59.981B 29.09
Baxter (BAX) United States $44.653B 27.08
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.674B 18.35
Lonza Group Ag (LZAGY) Switzerland $25.863B 0.00
Coloplast (CLPBY) Denmark $25.834B 41.24
Terumo (TRUMY) Japan $23.226B 26.71
Smith & Nephew SNATS (SNN) United Kingdom $20.906B 0.00
ResMed (RMD) United States $19.182B 36.58
Sunny Optical Technology (SNPTF) China $16.804B 0.00
Bio-Rad Laboratories (BIO) United States $10.124B 54.27
Insulet (PODD) United States $9.197B 544.96
Canopy Growth (CGC) Canada $9.163B 0.00
Perrigo (PRGO) Ireland $7.388B 13.61
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.984B 20.82
Haemonetics (HAE) United States $6.525B 49.24
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.265B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.167B 0.00
Neogen (NEOG) United States $4.002B 66.44
NuVasive (NUVA) United States $3.387B 27.00
ICU Medical (ICUI) United States $3.307B 21.45
Hutchison China MediTech (HCM) China $2.719B 0.00
Quidel (QDEL) United States $2.651B 26.33
Agios Pharmaceuticals (AGIO) United States $2.117B 0.00
National Vision Holdings (EYE) United States $2.015B 43.49
Cardiovascular Systems (CSII) United States $1.761B 0.00
Aphria (APHA) $1.519B 0.00
VAREX IMAGING (VREX) United States $1.090B 25.12
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $1.003B 26.37
Omeros (OMER) United States $0.896B 0.00
Phibro Animal Health (PAHC) United States $0.881B 14.34
Eagle Pharmaceuticals (EGRX) United States $0.802B 20.45
NanoString Technologies (NSTG) United States $0.801B 0.00
Cerus (CERS) United States $0.745B 0.00
PetIQ (PETQ) United States $0.730B 17.25
LeMaitre Vascular (LMAT) United States $0.709B 42.01
MacroGenics (MGNX) United States $0.636B 0.00
Surmodics (SRDX) United States $0.620B 117.92
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.599B 0.00
OraSure Technologies (OSUR) United States $0.462B 21.40
Meridian Bioscience (VIVO) United States $0.407B 12.71
BioLife Solutions (BLFS) United States $0.396B 130.13
Utah Medical Products (UTMD) United States $0.368B 26.98
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.351B 0.00
Owens & Minor (OMI) United States $0.349B 10.47
Zynex (ZYXI) United States $0.315B 33.45
United Health Products (UEEC) United States $0.270B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Cytosorbents (CTSO) United States $0.178B 0.00
Vapotherm (VAPO) United States $0.174B 0.00
Chimerix (CMRX) United States $0.143B 0.00
Fonar (FONR) United States $0.142B 10.11
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Female Health (VERU) United States $0.122B 0.00
United-Guardian (UG) United States $0.085B 20.07
Nephros (NEPH) United States $0.068B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Senestech (SNES) United States $0.027B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00